Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
mrossettiJune 24, 2019
Nous avons pris note de l’alerte lancée par la FDA (USA) concernant le décès d'un…
mrossettiJune 14, 2019
- First patents to cover the fundamental processes for accessing the human gut microbiome as…
mrossettiMay 21, 2019
“Caelus Health, EnteroBiotix, Ferring Pharmaceuticals, and MaaT Pharma, in coordination with the Pharmabiotic Research Institute…
mrossettiMay 21, 2019
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute…
mrossettiApril 9, 2019
Independent Data Safety Monitoring Board (DSMB) recommends to continue HERACLES study without modification. Lyon, France,…
mrossettiFebruary 5, 2019